Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Metadata
Title
Breastfeeding experience in inborn errors of metabolism other than phenylketonuria
Authors
G. Huner
T. Baykal
F. Demir
M. Demirkol
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 4/2005
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-005-0457-3

Other articles of this Issue 4/2005

Journal of Inherited Metabolic Disease 4/2005 Go to the issue

OriginalPaper

A survey of Japanese patients with Menkes disease from 1990 to 2003: Incidence and early signs before typical symptomatic onset, pointing the way to earlier diagnosis

Short Report

Absolute configuration of N-acetylaspartate in urine from patients with Canavan disease

OriginalPaper

Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing rats

OriginalPaper

The 625G>A SCAD gene variant is common but not associated with increased C4-carnitine in newborn blood spots

OriginalPaper

Management of methylmalonic acidaemia by combined liver–kidney transplantation

OriginalPaper

Instructions to Authors

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits